Back

State of the Art: PCSK9 - Beyond lipid-lowering effects?

27 August 2017 (16:30 - 16:48)
Organised by:
Congress Presentation Part of: PCSK9: Beyond lipid - lowering effects? Endothelial function ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Ulf Landmesser

Charite University Hospital, Berlin (Germany)

3 More presentations in this session

Presentation thumbnail
PCSK9 beyond its role in cholesterol homeostasis: co-activator of platelet function
Assistant Professor M. Camera (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Serum PCSK9 in relation to coronary near-infrared spectroscopy-derived lipid core burden index and long-term cardiovascular outcome [ATHEROREMO-NIRS substudy].
Miss S. Anroedh (Rotterdam, NL)
Abstract
Presentation thumbnail
PCSK9 inhibition: what do we know from clinical trials?
Professor J. Chapman (Paris, FR)
Slides Video

Access the full session

Session thumbnail
PCSK9: Beyond lipid - lowering effects?

The Event

Event poster

ESC Congress 2017

27 August 2017 16:30 CET
You may be interested in
thumbnail
Congress Presentation
The effect of proprotein convertase subtilisin/kexin type 9 inhibition on the plasma proteome: a SPIRE sub-study
28 August 2023
thumbnail
ESC TV Today
Episode 26: Lp(a): the future starts now - Myocardial infarction in older age and frailty
6 November 2025
thumbnail
Webinar
LDL-C reduction postACS: strike early and strike strong
15 November 2021
thumbnail
Congress Presentation
Pleiotropic effects of inclisiran on arterial structural and functional parameters
4 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources